Sökning: "FEC"
Visar resultat 11 - 15 av 29 avhandlingar innehållade ordet FEC.
11. Individually Tailored Toxicity-based Chemotherapy : Studies on Patients with Primary and Metastatic Breast Cancer
Sammanfattning : Standard dosing of chemotherapy based on body surface area (BSA) results in large individual differences in toxicity due to a large inter-patient variability in pharmacokinetics (PK) and pharmacodynamics (PD). This results in under-dosing in certain patients with a potentially weaker antitumoral effect. LÄS MER
12. Coherent Optical Transmission Systems : Performance and Coding Aspects
Sammanfattning : Since the invention of fiber-optic systems in the 1970s, user demand has driven innovation forward, and each new generation of products has achieved higher data rates than its predecessor. Today, the most promising approach for further increasing data rates is coherent transmission with multi-level modulation and digital signal processing (DSP). LÄS MER
13. On Reliable and Deadline-Constrained Communication in Wireless Industrial Networks
Sammanfattning : Along with the quick development of wireless communication technologies, industrial automation networks are also in unceasing evolution. Industrial wireless sensor and actuator networks (IWSAN) have been increasingly adopted in industrial automation systems. LÄS MER
14. Aspects of Power Consumption in Coherent Fiber-Optical Communication Systems
Sammanfattning : The power consumption of coherent fiber-optical communication systems is becoming increasingly important, for both environmental and economical reasons. The data traffic on the Internet is increasing at a faster pace than that at which optical network equipment is becoming more energy efficient, which means that the overall power consumption of the Internet is increasing. LÄS MER
15. Pharmacokinetics and Pharmacodynamics of Anti-Cancer Regimens : Emphasis on Busulphan and the Combination Therapies Epirubicin-Docetaxel and Fluorouracil-Epirubicin-Cyclophosphamide
Sammanfattning : Although the main reason for the lack of distinct dose-response and -toxicity relationships for anti-cancer agents is due to variability in pharmacodynamics, variability in pharmacokinetics may also contribute. Hence, not only describing and quantifying the relationship between pharmacokinetics and dose-limiting toxicities, but characterising the pharmacokinetics and its associated variability are of obvious importance in the process of developing dosing strategies for anti-cancer regimens. LÄS MER